3sbio competitorsClear all

3sbio's top competitors include BioNTech, TOT BIOPHARM, Iovance Biotherapeutics and Oncopeptides.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
3sbio
3sbio
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
BioNTech
BioNTech
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
TOT BIOPHARM
TOT BIOPHARM
TOT BIOPHARM is a biopharmaceutical company that develops oncology drugs and therapies.
Iovance Biotherapeutics
Iovance Biotherapeutics
Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes.
Oncopeptides
Oncopeptides
Oncopeptides is a clinical development pharmaceutical company.
Founding Date
Founding Date
1993
Founding Date
2008
Founding Date
2009
Founding Date
2013
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
George Town, KY HQ
Locations
Mainz, DE HQ
Halle (Saale), DE
Idar Oberstein, DE
Marburg, DE
Neuried, DE
Planegg, DE
Cambridge, US
see more
Locations
Suzhou Shi, CN HQ
Locations
San Carlos, US HQ
New York, US
Philadelphia, US
Philadelphia, US
Tampa, US
Locations
Stockholm, SE HQ
Stockholm, SE
Los Altos, US
Mountain View, US
Waltham, US
Employees
Employees
5,2325% decrease
Employees
1,94149% increase
Employees
3375% decrease
Employees
14868% increase
Employees
16250% decrease
Alexa Website Rank
Alexa Website Rank
302555
Alexa Website Rank
137148
Alexa Website Rank
563566
Alexa Website Rank
674367
Alexa Website Rank
765507
Employee Rating
Employee Rating
3
Employee Rating
3.3
Employee Rating
N/A
Employee Rating
3.1
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
¥6.4b (FY, 2021)
Revenue (est.)
€19b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
kr118.3m (FY, 2021)
Cost of goods
Cost of goods
(¥777.3m) (FY, 2021)
Cost of goods
(€2.9b) (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
(kr53.1m) (FY, 2021)
Gross profit
Gross profit
¥5.7b (FY, 2021)
Gross profit
€16.2b (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
kr132.8m (FY, 2021)
Net income
Net income
¥1.6b (FY, 2021)
Net income
€10.3b (FY, 2021)
Net income
N/A
Net income
($259.6m) (FY, 2020)
Net income
(kr1.4b) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 15.2m
Total funding raised
$ 1.4b
Total funding raised
$ 108m
Total funding raised
$ 100m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

BioNTech
HQ
Mainz, DE
Employees
1,941↑ 49% increase

BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.

View company
TOT BIOPHARM
HQ
Suzhou Shi, CN
Employees
337↓ 5% decrease

TOT BIOPHARM is a biopharmaceutical company that develops oncology drugs and therapies.

View company
Iovance Biotherapeutics
HQ
San Carlos, US
Employees
148

Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes.

View company
Oncopeptides
HQ
Stockholm, SE
Employees
162↓ 50% decrease

Oncopeptides is a clinical development pharmaceutical company.

View company